Topical fluorouracil for actinic keratoses and photoaging: A clinical and molecular analysis

Archives of Dermatology

Volumn 145, Issue 6, 2009, Pages 659-666

  Sachs, Dana L ^a,d   Kang, Sewon ^c   Hammerberg, Craig ^a   Helfrich, Yolanda ^a   Karimipour, Darius ^a   Orringer, Jeffrey ^a   Johnson, Timothy ^a   Hamilton, Ted A ^b   Fisher, Gary ^a   Voorhees, John J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYTOKERATIN 16; FLUOROURACIL; GELATINASE B; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MESSENGER RNA; PROCOLLAGEN; STROMELYSIN;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; EPIDERMIS; ERYTHEMA; FACE; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MEDICAL PHOTOGRAPHY; OPEN STUDY; PHOTOAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INFLAMMATION; SKIN IRRITATION; SKIN SWELLING; TISSUE REPAIR; TREATMENT RESPONSE; WOUND HEALING;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; PHOTOGRAPHY; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SKIN AGING; TREATMENT OUTCOME;

EID: 67449164591     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.97     Document Type: Article

References (28)

1. Berman B, Villa A, Ramirez C. Mechanisms of action of new treatment modalities for actinic keratosis. J Drugs Dermatol. 2006;5(2):167-173.
2. Falkson G, Schulz E. Skin changes in patients treated with 5-fluorouracil. Br J Dermatol. 1962;74:229-236.
3. Ghaneh P, Sultana A, Shore S, Stocken F, Neoptolemos J. The case for adjuvant chemotherapy in pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006; 20(2):383-401.
4. Ilson DH. Cancer of the gastroesophageal junction: current therapy options. Curr Treat Options Oncol. 2006;7(5):410-423. (Pubitemid 44339384)
5. Chung KY, Saltz L. Adjuvant therapy of colon cancer: current status and future directions. Cancer J. 2007;13(3):192-197.
6. Johnson TM, Rapini RP, Duvic M. Inflammation of actinic keratoses from systemic chemotherapy. J Am Acad Dermatol. 1987;17(2, pt 1):192-197. (Pubitemid 17130990)
7. Dillaha CJ, Jansen GT, Honeycutt WM, Bradford AC. Selective cytotoxic effect of topical 5-fluorouracil. Arch Dermatol. 1963;88:247-256.
8. Dillaha CJ, Jansen GT, Honeycutt WM, Holt GA. Further studies with topical 5-fluorouracil. Arch Dermatol. 1965;92(4):410-417.
9. Goldman L. The response of skin cancer to topical therapy with 5-fluorouracil. Cancer Chemother Rep. 1963;28:49-52.
10. Klein E, Stoll H Jr, Milgrom H, Helm F, Walker M. Tumors of the skin, XII: topical 5-fluorouracil for epidermal neoplasms. J Surg Oncol. 1971;3(3):331-349.
11. Williams AC, Klein E. Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesions. Cancer. 1970;25(2):450-462.
12. Arnold HL Jr, Williams RM, Kim R. Topical 5-fluorouracil for actinic keratoses. Geriatrics. 1968;23(7):115-117.
13. Sturm HM, Scott H. Treatment of actinic keratoses with topical 5-fluorouracil. J Med Assoc Ga. 1968;57(5):205-209.
14. Anderson L. Actinic keratosis - the advent of fluorouracil. J Kans Med Soc. 1973;74(8):306-309.
15. Breza T, Taylor R, Eaglstein W. Noninflammatory destruction of actinic keratoses by fluorouracil. Arch Dermatol. 1976;112(9):1256-1258.
16. Griffiths CE, Wang TS, Hamilton TA, Voorhees JJ, Ellis CN. A photonumeric scale for the assessment of cutaneous photodamage. Arch Dermatol. 1992;128(3):347-351.
17. Quan T, He T, Kang S, Voorhees JJ, Fisher GJ. Connective tissue growth factor: expression in human skin in vivo and inhibition by ultraviolet irradiation. J Invest Dermatol. 2002;118(3):402-408. (Pubitemid 34227155)
18. Rittié L, Kang S, Voorhees JJ, Fisher GJ. Induction of collagen by estradiol: difference between sun-protected and photodamaged human skin in vivo. Arch Dermatol. 2008;144(9):1129-1140.
19. Coulombe PA, Bravo NS, Paladini RD, Nguyen D, Takahashi K. Overexpression of human keratin 16 produces a distinct skin phenotype in transgenic mouse skin. Biochem Cell Biol. 1995;73(9-10):611-618.
20. Herouy Y. Matrix metalloproteinases in skin pathology. Int J Mol Med. 2001;7(1):3-12.
21. Orringer JS, Kang S, Johnson T, et al. Connective tissue remodeling induced by carbon dioxide laser resurfacing of photodamaged human skin. Arch Dermatol. 2004;140(11):1326-1332. (Pubitemid 39473631)
22. Fisher GJ, Kang S, Varani J, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2002;138(11):1462-1470. (Pubitemid 35315736)
23. Weinstock MA, Bingham SF, Cole GW, et al. Reliability of counting actinic keratoses before and after brief consensus discussion: the VA Topical Tretinoin Chemoprevention (VATTC) trial. Arch Dermatol. 2001;137(8):1055-1058. (Pubitemid 32756463)
24. Pearlman DL. Weekly pulse dosing: effective and comfortable topical 5-fluorouracil treatment of multiple facial actinic keratoses. J Am Acad Dermatol. 1991;25(4):665-667.
25. Epstein E. Does intermittent "pulse" topical 5-fluorouracil therapy allow destruction of actinic keratoses without significant inflammation? J Am Acad Dermatol. 1998;38(1):77-80.
26. Jury CS, Ramraka-Jones VS, Gudi V, Herd RM. A randomized trial of topical 5% 5-fluorouracil (Efudix cream) in the treatment of actinic keratoses comparing daily with weekly treatment. Br J Dermatol. 2005;153(4):808-810. (Pubitemid 41415910)
27. Orringer JS, Voorhees JJ, Hamilton T, et al. Dermal matrix remodeling after non-ablative laser therapy. J Am Acad Dermatol. 2005;53(5):775-782. (Pubitemid 41501362)
28. Karimipour DJ, Kang S, Johnson TM, et al. Microdermabrasion with and without aluminum oxide crystal abrasion: a comparative molecular analysis of dermal remodeling. J Am Acad Dermatol. 2006;54(3):405-410. (Pubitemid 43243441)